Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

immunization

- PMLiVE

Havas Life London unveils AI awareness campaign

The campaign highlights the dangers of AI misinformation in rare disease

- PMLiVE

The next era in life sciences: agentic AI and other innovations transforming HCP engagement

By Chris Moore

- PMLiVE

Scaling AI in healthcare communications: from pilots to living systems

By Andreas Reinbolz and Thomas Nisters

- PMLiVE

Clicks vs credibility: how social media underscores patient understanding

By Jordan Brand

- PMLiVE

Launch differently: how unforgettable brands break through

By Whitney Morley and Jo Crouch

- PMLiVE

Predicting the future of health equity in the pharmaceutical industry

By Natalia Barkalina and Noah Froud

- PMLiVE

How smart scaling and strategic implementation of AI are transforming life sciences

By Jo Ann Saitta

- PMLiVE

Redefining digital ROI: Engagement, experience, and the new metrics of success

Clicks and engagement only tell part of the story. In this webinar, pharma leaders discuss how to move beyond traditional KPIs to measure real impact and ROI from digital and...

Graphite Digital

- PMLiVE

AstraZeneca’s Enhertu combination approved by FDA for HER2-positive breast cancer

Around one in five breast cancer cases are HER2-positive

- PMLiVE

Medicus Pharma completes patient enrolment for basal cell carcinoma trial

Interim results have shown over 60% clinical clearance in patients treated with SkinJect

Headshot of Sarah Theobald with text reading 'Healthcare communications trends in 2026'

What will healthcare communications look like in 2026? Amiculum’s prediction of upcoming trends

By Sarah Theobald

Amiculum

- PMLiVE

FDA approves first gene therapy for Wiskott-Aldrich syndrome

Symptoms of the rare disease include bleeding, eczema and frequent infections

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links